1. Agid, Y., Javoy-Agid, F., 1985, Peptides and Parkinson’s disease, TINS, 8: 30–36.
2. Bedard, P., Langelier, P., Villeneuve, A., 1977, Oestrogens and extrapiramidal system. Lancet, II: 1367–1368.
3. Bedard, P., Dankova, J., Boucher, R., Langelier, P., 1978, Effect of estrogens on apomorphine-induced circling behaviour in the rat. Can. J. Physiol. Pharmacol., 65: 538–541.
4. Bedard, P., Langelier, P., Dankova, J., Villeneuve, A., Di Paolo, T., Barden, N., Labrie, F., Boissier, J.R., Euvrard, C., 1979, Estrogens, progesterone, and the extrapyramidal system, Adv. Neurol., 24: 411–422.
5. Brown, E., Brown, G.H., Kofman, O., Quarrington, B., 1978, Sexual function and affect in parkinsonian men treated with 1-Dopa. Am. J. Psychiatry, 135: 1552–1555.